The significance of thrombocytosis in patients with locally advanced cervical carcinoma

A gynecologic oncology group study

Enrique Hernandez, Kathleen A. Donohue, Lisa L. Anderson, Paul B. Heller, Frederick Stehman

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

Objective. The aim of this study was to determine the incidence of thrombocytosis and its possible impact on survival probability among women with locally advanced cervical carcinoma. Methods. The database of 294 patients with Stages IIB-IVA cervical carcinoma without periaortic node metastasis who were treated with standardized radiation therapy and concurrent hydroxyurea or misonidazole was analyzed. Pretreatment platelet counts were available for 291 patients who are the subject of this study. Results. Thrombocytosis (platelet count >400 x 109/liter) was present in 86 (29.6%) of the 291 patients. A multivariate Cox proportional hazards model showed that patients without extrapelvic disease and with thrombocytosis had a 55% greater chance of dying than those without thrombocytosis (relative risk = 1.55, 95% confidence interval 1.08-2.21). Patients with thrombocytosis had larger tumors and more frequently had bilateral parametrial involvement, tumor fixation to the sidewall, and positive pelvic lymph nodes than patients without thrombocytosis. Thrombocytosis was not found to be a prognostic factor in patients with positive pelvic nodes. However, in patients with negative pelvic nodes, the presence or absence of thrombocytosis was related to survival. Conclusion. Thrombocytosis is a frequent finding among patients with advanced cervical carcinoma and seems to be related to tumor burden. Among patients with locally advanced cervical carcinoma who had negative pelvic nodes, those with thrombocytosis had a poorer survival. (C)

Original languageEnglish
Pages (from-to)137-142
Number of pages6
JournalGynecologic Oncology
Volume78
Issue number2
DOIs
StatePublished - 2000

Fingerprint

Thrombocytosis
Carcinoma
Platelet Count
Survival
Misonidazole
Hydroxyurea
Tumor Burden
Proportional Hazards Models
Neoplasms
Radiotherapy
Lymph Nodes
Databases
Confidence Intervals
Neoplasm Metastasis

Keywords

  • Carcinoma
  • Cervical
  • Incidence
  • Prognosis
  • Survival
  • Thrombocytosis

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

The significance of thrombocytosis in patients with locally advanced cervical carcinoma : A gynecologic oncology group study. / Hernandez, Enrique; Donohue, Kathleen A.; Anderson, Lisa L.; Heller, Paul B.; Stehman, Frederick.

In: Gynecologic Oncology, Vol. 78, No. 2, 2000, p. 137-142.

Research output: Contribution to journalArticle

Hernandez, Enrique ; Donohue, Kathleen A. ; Anderson, Lisa L. ; Heller, Paul B. ; Stehman, Frederick. / The significance of thrombocytosis in patients with locally advanced cervical carcinoma : A gynecologic oncology group study. In: Gynecologic Oncology. 2000 ; Vol. 78, No. 2. pp. 137-142.
@article{6f94f732181948ca9c7bec768318a791,
title = "The significance of thrombocytosis in patients with locally advanced cervical carcinoma: A gynecologic oncology group study",
abstract = "Objective. The aim of this study was to determine the incidence of thrombocytosis and its possible impact on survival probability among women with locally advanced cervical carcinoma. Methods. The database of 294 patients with Stages IIB-IVA cervical carcinoma without periaortic node metastasis who were treated with standardized radiation therapy and concurrent hydroxyurea or misonidazole was analyzed. Pretreatment platelet counts were available for 291 patients who are the subject of this study. Results. Thrombocytosis (platelet count >400 x 109/liter) was present in 86 (29.6{\%}) of the 291 patients. A multivariate Cox proportional hazards model showed that patients without extrapelvic disease and with thrombocytosis had a 55{\%} greater chance of dying than those without thrombocytosis (relative risk = 1.55, 95{\%} confidence interval 1.08-2.21). Patients with thrombocytosis had larger tumors and more frequently had bilateral parametrial involvement, tumor fixation to the sidewall, and positive pelvic lymph nodes than patients without thrombocytosis. Thrombocytosis was not found to be a prognostic factor in patients with positive pelvic nodes. However, in patients with negative pelvic nodes, the presence or absence of thrombocytosis was related to survival. Conclusion. Thrombocytosis is a frequent finding among patients with advanced cervical carcinoma and seems to be related to tumor burden. Among patients with locally advanced cervical carcinoma who had negative pelvic nodes, those with thrombocytosis had a poorer survival. (C)",
keywords = "Carcinoma, Cervical, Incidence, Prognosis, Survival, Thrombocytosis",
author = "Enrique Hernandez and Donohue, {Kathleen A.} and Anderson, {Lisa L.} and Heller, {Paul B.} and Frederick Stehman",
year = "2000",
doi = "10.1006/gyno.2000.5838",
language = "English",
volume = "78",
pages = "137--142",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - The significance of thrombocytosis in patients with locally advanced cervical carcinoma

T2 - A gynecologic oncology group study

AU - Hernandez, Enrique

AU - Donohue, Kathleen A.

AU - Anderson, Lisa L.

AU - Heller, Paul B.

AU - Stehman, Frederick

PY - 2000

Y1 - 2000

N2 - Objective. The aim of this study was to determine the incidence of thrombocytosis and its possible impact on survival probability among women with locally advanced cervical carcinoma. Methods. The database of 294 patients with Stages IIB-IVA cervical carcinoma without periaortic node metastasis who were treated with standardized radiation therapy and concurrent hydroxyurea or misonidazole was analyzed. Pretreatment platelet counts were available for 291 patients who are the subject of this study. Results. Thrombocytosis (platelet count >400 x 109/liter) was present in 86 (29.6%) of the 291 patients. A multivariate Cox proportional hazards model showed that patients without extrapelvic disease and with thrombocytosis had a 55% greater chance of dying than those without thrombocytosis (relative risk = 1.55, 95% confidence interval 1.08-2.21). Patients with thrombocytosis had larger tumors and more frequently had bilateral parametrial involvement, tumor fixation to the sidewall, and positive pelvic lymph nodes than patients without thrombocytosis. Thrombocytosis was not found to be a prognostic factor in patients with positive pelvic nodes. However, in patients with negative pelvic nodes, the presence or absence of thrombocytosis was related to survival. Conclusion. Thrombocytosis is a frequent finding among patients with advanced cervical carcinoma and seems to be related to tumor burden. Among patients with locally advanced cervical carcinoma who had negative pelvic nodes, those with thrombocytosis had a poorer survival. (C)

AB - Objective. The aim of this study was to determine the incidence of thrombocytosis and its possible impact on survival probability among women with locally advanced cervical carcinoma. Methods. The database of 294 patients with Stages IIB-IVA cervical carcinoma without periaortic node metastasis who were treated with standardized radiation therapy and concurrent hydroxyurea or misonidazole was analyzed. Pretreatment platelet counts were available for 291 patients who are the subject of this study. Results. Thrombocytosis (platelet count >400 x 109/liter) was present in 86 (29.6%) of the 291 patients. A multivariate Cox proportional hazards model showed that patients without extrapelvic disease and with thrombocytosis had a 55% greater chance of dying than those without thrombocytosis (relative risk = 1.55, 95% confidence interval 1.08-2.21). Patients with thrombocytosis had larger tumors and more frequently had bilateral parametrial involvement, tumor fixation to the sidewall, and positive pelvic lymph nodes than patients without thrombocytosis. Thrombocytosis was not found to be a prognostic factor in patients with positive pelvic nodes. However, in patients with negative pelvic nodes, the presence or absence of thrombocytosis was related to survival. Conclusion. Thrombocytosis is a frequent finding among patients with advanced cervical carcinoma and seems to be related to tumor burden. Among patients with locally advanced cervical carcinoma who had negative pelvic nodes, those with thrombocytosis had a poorer survival. (C)

KW - Carcinoma

KW - Cervical

KW - Incidence

KW - Prognosis

KW - Survival

KW - Thrombocytosis

UR - http://www.scopus.com/inward/record.url?scp=0033847375&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033847375&partnerID=8YFLogxK

U2 - 10.1006/gyno.2000.5838

DO - 10.1006/gyno.2000.5838

M3 - Article

VL - 78

SP - 137

EP - 142

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 2

ER -